Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (8): 754-756.DOI: 10.3969/j.issn.1673-8640.2022.08.010
Previous Articles Next Articles
Received:2021-07-28
Revised:2021-12-28
Online:2022-08-30
Published:2022-09-16
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.08.010
| 项目 | HCT/% | Hb/（g/L） | MCH/pg | MCHC/ （g/L） | MCV/fL | PLT/ （×109/L） | RBC/ （×1012/L） | WBC/ （×109/L） |
|---|---|---|---|---|---|---|---|---|
| 纠正前 | 34.30±5.62 | 133.61±15.65 | 90.15±11.52 | 394.75±44.71 | 38.50±11.76 | 236.82±54.86 | 3.74±0.67 | 6.64±1.73 |
| 纠正后 | 37.58±3.98 | 133.32±15.59 | 86.65±11.18 | 354.39±8.05 | 33.68±11.88 | 241.57±66.43 | 4.24±0.45 | 6.80±1.79 |
| 统计值 | -4.326 | -1.000 | -4.601 | -4.256 | -4.255 | -1.728 | -4.264 | -5.865 |
| P值 | 0.000 | 0.317 | 0.000 | 0.000 | 0.000 | 0.084 | 0.000 | 0.000 |
| 项目 | HCT/% | Hb/（g/L） | MCH/pg | MCHC/ （g/L） | MCV/fL | PLT/ （×109/L） | RBC/ （×1012/L） | WBC/ （×109/L） |
|---|---|---|---|---|---|---|---|---|
| 纠正前 | 34.30±5.62 | 133.61±15.65 | 90.15±11.52 | 394.75±44.71 | 38.50±11.76 | 236.82±54.86 | 3.74±0.67 | 6.64±1.73 |
| 纠正后 | 37.58±3.98 | 133.32±15.59 | 86.65±11.18 | 354.39±8.05 | 33.68±11.88 | 241.57±66.43 | 4.24±0.45 | 6.80±1.79 |
| 统计值 | -4.326 | -1.000 | -4.601 | -4.256 | -4.255 | -1.728 | -4.264 | -5.865 |
| P值 | 0.000 | 0.317 | 0.000 | 0.000 | 0.000 | 0.084 | 0.000 | 0.000 |
| 项目 | HCT/% | Hb/（g/L） | MCH/pg | MCHC/ （g/L） | MCV/fL | PLT/ （×109/L） | RBC/ （×1012/L） | WBC/ （×109/L） |
|---|---|---|---|---|---|---|---|---|
| 纠正前 | 37.06±7.84 | 154±38.16 | 36.92±2.60 | 414.00±29.39 | 89.38±7.25 | 241.8±122.14 | 4.22±1.17 | 12.09±2.66 |
| 纠正后 | 35.78±8.27 | 129±35.71 | 31.84±1.18 | 356.00±23.10 | 89.64±7.71 | 244.4±144.39 | 4.17±1.29 | 11.64±3.25 |
| 统计值 | 1.177 | 3.845 | 4.124 | -0.119 | -0.677 | 0.477 | 0.818 | 1.177 |
| P值 | 0.304 | 0.018 | 0.015 | 0.911 | 0.498 | 0.658 | 0.459 | 0.304 |
| 项目 | HCT/% | Hb/（g/L） | MCH/pg | MCHC/ （g/L） | MCV/fL | PLT/ （×109/L） | RBC/ （×1012/L） | WBC/ （×109/L） |
|---|---|---|---|---|---|---|---|---|
| 纠正前 | 37.06±7.84 | 154±38.16 | 36.92±2.60 | 414.00±29.39 | 89.38±7.25 | 241.8±122.14 | 4.22±1.17 | 12.09±2.66 |
| 纠正后 | 35.78±8.27 | 129±35.71 | 31.84±1.18 | 356.00±23.10 | 89.64±7.71 | 244.4±144.39 | 4.17±1.29 | 11.64±3.25 |
| 统计值 | 1.177 | 3.845 | 4.124 | -0.119 | -0.677 | 0.477 | 0.818 | 1.177 |
| P值 | 0.304 | 0.018 | 0.015 | 0.911 | 0.498 | 0.658 | 0.459 | 0.304 |
| [1] | 郜红琴, 闫华, 苗慧丽. 红细胞冷凝集现象对血常规检验结果的影响及几种消除方法比较[J]. 长治医学院学报, 2014, 28(6):453-455. |
| [2] |
ROCCAFORTE V, SCIARINI F, PROSERPIO V, et al. Use of the reticulocyte channel warmed to 41°C of the XN-9000 analyzer in samples with the presence of cold agglutinins[J]. Hematol Transfus Cell Ther, 2021, 43(2):147-155.
DOI URL |
| [3] | 周益花, 于农. 红细胞冷凝集现象对血常规检验结果影响分析[J]. 临床检验杂志(电子版), 2020, 9(2):209. |
| [4] | 张时民, 于连辉. 乳糜血对血常规中HGB、MCH、MCHC的影响及排除方法探讨[C]//. 中华医学会第七次全国检验医学学术会议资料汇编, 2008. |
| [5] | 傅岩, 刘曙光. 儿童遗传性球形红细胞增多症中MCHC的特异性[J]. 军医进修学院学报, 2011, 32(6):594-595. |
| [6] |
BARNES P W, MCFADDEN S L, MACHIN S J, et al. The international consensus group for hematology review:suggested criteria for action following automated CBC and WBC differential analysis[J]. Lab Hematol, 2005, 11(2):83-90.
DOI URL |
| [7] | 李婷婷. 高血脂患者乳糜血对血常规检测指标的影响[J]. 中外医疗, 2015, 34(4):181-182. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
